![The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review](https://benthamopen.com/contents/figures/TOPAINJ/TOPAINJ-13-7_F1.jpg)
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
![A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40122-019-00143-6/MediaObjects/40122_2019_143_Fig2_HTML.png)
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | Pain and Therapy
![Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization | Journal of Neuroscience Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/29/22/7341/F1.large.jpg)
Buprenorphine Is a Weak Partial Agonist That Inhibits Opioid Receptor Desensitization | Journal of Neuroscience
![Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-B978012420118700010X-f10-01-9780124201187.jpg)
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
![Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine](https://www.frontierspartnerships.org/files/Articles/10009/adar-01-10009-HTML-r4/image_m/adar-01-10009-g001.jpg)
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
![Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.npp.1300251/MediaObjects/41386_2003_Article_BF1300251_Fig1_HTML.gif)
Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers | Neuropsychopharmacology
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist](https://www.naabt.org/images/tech_2.jpg)
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-021-01032-7/MediaObjects/40261_2021_1032_Fig1_HTML.png)
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder | Clinical Drug Investigation
![Table 1 from Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. | Semantic Scholar Table 1 from Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ce5294b2baee273c42748400115deb9255da5bec/2-Table1-1.png)